Related Experiment Video

Updated: Jun 4, 2026

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
13:38

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

Steroid sulfatase inhibitors: promising new tools for breast cancer therapy?

Jürgen Geisler1, Hironobu Sasano, Shiuan Chen

  • 1Institute of Clinical Medicine, Division of Clinical Medicine and Laboratory Sciences, University of Oslo, Norway. juergen.geisler@medisin.uio.no

The Journal of Steroid Biochemistry and Molecular Biology
|March 2, 2011
PubMed

Insights

Steroid sulfatase (STS) is a promising target for hormone-dependent breast cancer, offering an alternative to aromatase inhibitors. Inhibiting STS may overcome endocrine resistance and prevent cancer relapse.

Area of Science:

  • Endocrinology
  • Oncology
  • Pharmacology

Background:

  • Aromatase inhibitors are standard for postmenopausal hormone-dependent breast cancer.
  • Endocrine resistance limits the efficacy of current treatments, leading to disease relapse and metastasis.

Purpose of the Study:

  • To review the biology of steroid sulfatase (STS).
  • To discuss the potential of STS inhibition as a therapeutic strategy for breast cancer.
  • To summarize current research and early clinical trial data on STS inhibitors.

Main Methods:

  • Review of existing literature on steroid sulfatase biology and inhibition.
  • Analysis of preclinical and early clinical trial data in breast cancer.

Main Results:

  • Steroid sulfatase (STS) converts steroid sulfates to active hormones, potentially fueling hormone-sensitive breast cancer.
  • Inhibition of STS represents a novel therapeutic avenue to overcome endocrine resistance.

Conclusions:

  • STS is a promising drug target for breast cancer treatment.
  • Further research and clinical trials are warranted to evaluate STS inhibitors.

More Related Videos

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...